TCT 2017: Dr. C. Michael Gibson talks with Dr. Gregg Stone about ABSORB IV

30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease